Close Menu

NEW YORK (360Dx) ­–Blood analysis systems firm Abaxis today reported flat revenues for the third quarter of fiscal 2016 in preliminary results, due in part to a difficult to compare quarter and currency effects.

The firm, which markets instruments and consumables for the veterinary and medical spaces, expects revenues of $52 to $53 million in the quarter ended Dec. 31, 2016, flat with the comparable quarter last year and below the average Wall Street estimate of $58 million.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Nov
14
Sponsored by
Qiagen

This webinar will discuss some of the issues laboratories face when transitioning to next-generation sequencing, and the key features to be considered for a successful implementation in routine testing.

Dec
02
Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.